RECRUITING

PICO- Single-use Negative Pressure Wound Therapy System

Description

To compare the rate of wound complications with the PICO dressing versus a standard nonstick gauze dressing in patients undergoing anterior total ankle arthroplasty.

Conditions

Total Ankle Arthroplasty
Talk to us

Related Conditions:

Total Ankle Arthroplasty

Study Overview

On this page

Study Details

Study overview

To compare the rate of wound complications with the PICO dressing versus a standard nonstick gauze dressing in patients undergoing anterior total ankle arthroplasty.

Prospective Comparison of Wound Complications After Anterior Total Ankle Arthroplasty With and Without PICO Negative Pressure Incisional Dressing

PICO- Single-use Negative Pressure Wound Therapy System

Condition
Total Ankle Arthroplasty
Intervention / Treatment

-

Contacts and Locations

Baltimore

Amy Loveland, Baltimore, Maryland, United States, 21218

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient ≥18 years old
  • * Subjects undergoing total ankle arthroplasty or uncomplicated revision total ankle arthroplasty
  • * Subjects able to provide informed consent
  • * Subjects who are able to understand and comply with study visit schedule and procedures
  • * History of previous deep infection or history of wound complication necessitating plastic surgery intervention
  • * Allergy to products used in the study
  • * Pregnant and breastfeeding women due to anesthesia risks
  • * Subjects with a known history of poor compliance with medical treatment
  • * Subjects who decline participation in this research study
  • * Prisoners

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Walter C Hembree,

Walter C Hembree, MD, PRINCIPAL_INVESTIGATOR, MedStar Health

Study Record Dates

2025-09-30